Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Dayani Center for Health and Wellness, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Lymphat Res Biol. 2022 Aug;20(4):382-390. doi: 10.1089/lrb.2021.0039. Epub 2021 Nov 8.
Lipedema is a distinct adipose disorder from obesity necessitating awareness as well as different management approaches to address pain and optimize quality of life (QoL). The purpose of this proof-of-principle study is to evaluate the therapeutic potential of physical therapy interventions in women with lipedema. Participants with Stage 1-2 lipedema and early Stage 0-1 lymphedema ( = 5, age = 38.4 ± 13.4 years, body mass index = 27.2 ± 4.3 kg/m) underwent nine visits of physical therapy in 6 weeks for management of symptoms impacting functional mobility and QoL. Pre- and post-therapy, participants were scanned with 3 Tesla sodium and water magnetic resonance imaging (MRI), underwent biophysical measurements, and completed questionnaires measuring function and QoL (patient-specific functional scale, PSFS, and RAND-36). Pain was measured at each visit using the 0-10 visual analog scale (VAS). Treatment effect was calculated for all study variables. The primary symptomatology measures of pain and function revealed clinically significant post-treatment improvements and large treatment effects (Cohen's for pain VAS = -2.5 and PSFS = 4.4). The primary sodium MRI measures, leg skin sodium, and subcutaneous adipose tissue (SAT) sodium, reduced following treatment and revealed large treatment effects (Cohen's for skin sodium = -1.2 and SAT sodium = -0.9). This proof-of-principle study provides support that persons with lipedema can benefit from physical therapy to manage characteristic symptoms of leg pain and improve QoL. Objective MRI measurement of reduced tissue sodium in the skin and SAT regions indicates reduced inflammation in the treated limbs. Further research is warranted to optimize the conservative therapy approach in lipedema, a condition for which curative and disease-modifying treatments are unavailable.
脂肪水肿是一种与肥胖不同的脂肪组织疾病,需要提高认识,并采取不同的管理方法来缓解疼痛和优化生活质量(QoL)。本原理验证研究的目的是评估物理治疗干预对脂肪水肿患者的治疗潜力。患有 1-2 期脂肪水肿和早期 0-1 期淋巴水肿的参与者( = 5,年龄 = 38.4 ± 13.4 岁,体重指数 = 27.2 ± 4.3 kg/m)在 6 周内接受了 9 次物理治疗,以控制影响功能活动和生活质量的症状。在治疗前后,参与者接受了 3 特斯拉钠水磁共振成像(MRI)扫描、生物物理测量,并完成了测量功能和生活质量的问卷(特定患者功能量表,PSFS 和 RAND-36)。在每次就诊时使用 0-10 视觉模拟量表(VAS)测量疼痛。计算了所有研究变量的治疗效果。疼痛和功能的主要症状测量显示治疗后有临床意义的改善和较大的治疗效果(VAS 的 Cohen's 为-2.5,PSFS 的 Cohen's 为 4.4)。腿部皮肤钠和皮下脂肪组织(SAT)钠的主要钠 MRI 测量值在治疗后降低,且治疗效果较大(皮肤钠的 Cohen's 为-1.2,SAT 钠的 Cohen's 为-0.9)。本原理验证研究表明,脂肪水肿患者可以从物理治疗中获益,以缓解腿部疼痛的特征性症状并提高生活质量。皮肤和 SAT 区域组织钠的客观 MRI 测量值表明治疗肢体的炎症减轻。需要进一步研究来优化脂肪水肿的保守治疗方法,因为这种疾病目前尚无治愈和改善疾病的治疗方法。